Form 4: National Healthcare Corp SVP, CFO Brian F. Kidd Reports Option Grant
SEC Form 4
Brian F. Kidd, SVP and CFO of National Healthcare Corp, reports the grant of 13,500 stock options.
Summary
- Brian F. Kidd, SVP and CFO of National Healthcare Corp [NHC], reported a transaction on February 24, 2025.
- Kidd was granted 13,500 options to purchase common stock at an exercise price of $90.62.
- These options were granted pursuant to the 2020 Omnibus Equity Incentive Plan.
- The options vest ratably over three years, beginning February 24, 2026.
- Kidd directly owns 21,263 shares of common stock.
- Kidd also holds options to purchase 3,734 shares at $63.96, 8,000 shares at $53.94 and 12,000 shares at $94.1.
Sentiment
Score: 7
Explanation: The document is a routine disclosure of stock option grants, which is generally viewed neutrally to positively as it incentivizes management. The sentiment is slightly positive as it indicates continued investment in the company by the executive.
Positives
- The grant of stock options aligns the executive's interests with those of the shareholders.
Future Outlook
The document outlines the vesting schedule for the granted stock options, indicating future equity ownership for the reporting person.
Industry Context
Stock option grants are a common form of executive compensation in the healthcare industry, aligning management's interests with shareholder value.
Stakeholder Impact
- The stock option grant could potentially impact shareholders by diluting equity if the options are exercised.
- The stock option grant incentivizes the executive to improve company performance, which could benefit all stakeholders.
Key Dates
| Date | Description |
|---|---|
| 02/18/2023 | Date of exercisability for options to purchase 3,734 shares at $63.96 |
| 02/18/2027 | Expiration date for options to purchase 3,734 shares at $63.96 |
| 03/08/2024 | Date of exercisability for options to purchase 8,000 shares at $53.94 |
| 03/08/2028 | Expiration date for options to purchase 8,000 shares at $53.94 |
| 03/05/2025 | Date of exercisability for options to purchase 12,000 shares at $94.1 |
| 02/24/2025 | Date of transaction: Grant of 13,500 stock options at $90.62 |
| 02/24/2026 | First vesting date for the newly granted options (1/3 of 13,500 options) |
| 02/24/2027 | Second vesting date for the newly granted options (1/3 of 13,500 options) |
| 03/05/2029 | Expiration date for options to purchase 12,000 shares at $94.1 |
| 02/24/2028 | Final vesting date for the newly granted options (1/3 of 13,500 options) |
| 02/24/2030 | Expiration date for the newly granted options |
| 02/26/2025 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.